ABIN2480961

antibody from antibodies-online

Targeting: CD55 CR, CROM, DAF, TC

Western blot (Recommended by provider)

Immunoprecipitation (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

ABIN2480961

Provider

antibodies-online

Product name

anti-Complement Decay-Accelerating Factor (CD55) antibody

Antibody type

Monoclonal

Description

Purified

Reactivity

Human

Host

Mouse

Isotype

IgG

Antibody clone number

BRIC216

Vial size

0.2 mg

References

Submitted references

Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome.

Liszewski MK, Leung MK, Schraml B, Goodship TH, Atkinson JP
Molecular immunology 2007 Mar;44(7):1559-68

---

Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo.

Loberg RD, Day LL, Dunn R, Kalikin LM, Pienta KJ
Neoplasia (New York, N.Y.) 2006 Jan;8(1):69-78

---

Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor.

Coyne KE, Hall SE, Thompson S, Arce MA, Kinoshita T, Fujita T, Anstee DJ, Rosse W, Lublin DM
Journal of immunology (Baltimore, Md. : 1950) 1992 Nov 1;149(9):2906-13

---

Effects of acetate dialysate on transforming growth factor beta 1, interleukin, and beta 2-microglobulin plasma levels.

Anderson J, Briefel G, Jones JM, Ryu JH, McGuire M, Yun YP
Kidney international 1991 Dec;40(6):1110-7